What is Balance Labs, Inc. (BLNC) stock price today?

Balance Labs, Inc. (BLNC) is currently trading at $1.55, up 0% today.

What is BLNC P/E ratio?

Balance Labs, Inc.'s P/E ratio is -1.27. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BLNC return on equity (ROE)?

Balance Labs, Inc.'s return on equity (ROE) is 627.13%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Balance Labs, Inc.'s market cap?

Balance Labs, Inc. has a market capitalization of $72.62M.

OTC · Consulting Services

Balance Labs, Inc. (BLNC) Stock

$1.55 +0.00% OTC: BLNC Industrials

Balance Labs, Inc. functions as a specialized consultancy, delivering business development and strategic guidance to emerging and growth-phase companies in both domestic U.S.

Valuation

Metric	Value
Price	$1.55
Market Cap	$72.62M
P/E Ratio	-1.27
P/B Ratio	-25.31
P/S Ratio	1878.12
EPS (TTM)	$-1.23
52-Week High	$6.04
52-Week Low	$0.15
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	627.13%
ROA	—
ROCE	471.00%
Gross Margin	-493.72%
Operating Margin	—
Net Margin	—
Debt/Equity	-0.17
Current Ratio	0.08

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.0M	$0	$0	$0	$0
Operating Profit	$0	$0	$0	$0	$-13.0M
Net Profit	$-1.0M	$-1.0M	$0	$-1.0M	$-32.0M
EPS	$-0.04	$-0.04	$-0.02	$-0.02	$-1.23
Op Margin	35.9%	-9.2%	—	—	-218426.8%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$0	$0	$0	$0
Total Liabilities	$4.0M	$5.0M	$5.0M	$5.0M	$4.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$2.0M	$2.0M	$2.0M	$3.0M	$1.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$0	$0	$0	$0	$0
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-4.54
FCF Yield	-0.42%
Quick Ratio	0.08
Interest Coverage	-83.72
Return 1Y	933.33%
Return 3Y	559.57%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
APEUFAtlas Engineered Products Ltd.	$0.46	+0.00%	-34.08	$32.22M	0.00%
AQUEFVeloryx Ltd	$0.38	+0.00%	-0.92	$7.59M	0.00%
ECLMFEcolomondo Corporation	$0.08	+0.00%	-7.77	$17.55M	0.00%
GNOLFGenoil Inc.	$0.01	+0.00%	-24.75	$19.98M	0.00%
JANLJanel Corporation	$47.00	+0.00%	12.98	$55.76M	0.00%

About Balance Labs, Inc.

Balance Labs, Inc. functions as a specialized consultancy, delivering business development and strategic guidance to emerging and growth-phase companies in both domestic U.S. and international markets. The firm assists diverse enterprises in fine-tuning their core business frameworks, optimizing sales and marketing strategies, and improving internal operations. It also acts as a conduit, providing introductions to vital professional services, such as business plan formulation, accounting expertise, and legal support. Beyond these foundational services, Balance Labs plays an active role in the conceptualization and implementation of a broad spectrum of initiatives. This includes holistic business model design (encompassing market analysis, nomenclature, and brand identity), sophisticated financial modeling, the creation of websites and mobile applications, and the strategic recruitment of both staff and board members. The company further extends its support to patent and trademark application processes, product or service innovation and manufacturing, the development of compelling marketing collateral, strategic product/service positioning, the procurement of celebrity endorsements, and connecting clients with specialized legal and accounting professionals. Established in 2014 and headquartered in Miami Beach, Florida, Balance Labs, Inc. is a wholly-owned subsidiary of Balance Holdings, LLC.

Balance Labs, Inc. is headquartered in US.

Balance Labs, Inc. (BLNC) stock trades at $1.55 with a market capitalization of $72.62M. The stock is valued at a price-to-earnings (P/E) ratio of -1.27, price-to-book of -25.31, price-to-sales of 1878.12. Over the past 52 weeks the stock has ranged between $0.15 and $6.04, and currently trades 74.3% below its 52-week high.

On profitability, Balance Labs, Inc. generates a return on equity (ROE) of 627.13% — well above the market average, a sign of a high-quality business, return on capital employed of 471.00%.

Official website: www.balancelabs.co